Pierre Sesques

ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 10

Top Venues

Blood advances

American journal of hematology

Hematological oncology

Cancers

This page only lists publications with an associated author ORCID identifier.

Publications

Vincent Camus, Roch Houot, Gabriel Brisou, Benoît Tessoulin, Sebastien Bailly, Pierre Sesques, Justine Decroocq, Daphné Krzisch, Lucie Oberic, François Lemonnier, Krimo Bouabdallah, Arnaud Campidelli, Ledraa Tounes, Julie Abraham, Charles Herbaux, Judith Trotman, Gandhi Laurent Damaj, Stéphanie Guidez, Sylvain Carras, Luc-Matthieu Fornecker, Sylvain Choquet, Olivier Hermine, Jérôme Paillassa, Adrien Chauchet, Olivier Casasnovas, Laurianne Drieu La Rochelle, Cristina Castilla-Llorente, Magalie Joris, Vivien Dupont, Alexandra Marquet, Steven Le Gouill, Fabrice Jardin
Outcome of large B-cell lymphoma patients treated with tafasitamab plus lenalidomide either before or after CAR-T-cells. Blood advances (2024)
Vincent Camus, Mathieu Viennot, Pierre-Julien Viailly, Fanny Drieux, Elena-Liana Veresezan, Victor Bobée, Vinciane Rainville, Elodie Bohers, Pierre Sesques, Corinne Haioun, Eric Durot, Michael Bayaram, Cédric Rossi, Laurent Martin, Dominique Penther, Sophie Kaltenbach, Julie Bruneau, Jérôme Paillassa, Olivier Tournilhac, Nicolas Gower, Alexandre Willaume, Chloe Antier, Richard Greil, Emilie Leveque, Pierre Decazes, Stéphanie Becker, David Tonnelet, Philippe Gaulard, Hervé Tilly, Thierry Molina, Alexandra Traverse-Glehen, Marie Donzel, Philippe Ruminy, Fabrice Jardin
Identification of primary mediastinal B-cell lymphomas with higher clonal dominance and poorer outcome using 5' RACE. Blood advances (2024)
Caroline Le Lan, Aurélien Belot, Camille Golfier, Bérénice Audin, Pierre Sesques, Adeline Bernier, Violaine Safar, Emmanuelle Ferrant, Anne Lazareth, Hélène Lequeu, Lionel Karlin, Dana Ghergus, Alizée Maarek, Guillaume Aussedat, Maryam Idlhaj, Gilles Andre Salles, Fanny Cherblanc, Emmanuel Bachy, Hervé Ghesquières
Evaluation of participation and recruitment bias in a prospective Real World Data in Lymphoma and Survival in Adults (REALYSA) cohort for newly diagnosed lymphoma patients over 1 year in a hematology department of teaching hospital. Hematological oncology 42 (4) (2024)
Vincent Camus, Pierre-Julien Viailly, Fanny Drieux, Elena-Liana Veresezan, Pierre Sesques, Corinne Haioun, Eric Durot, Martine Patey, Cédric Rossi, Laurent Martin, Vinciane Rainville, Elodie Bohers, Philippe Ruminy, Dominique Penther, Sophie Kaltenbach, Julie Bruneau, Jérôme Paillassa, Olivier Tournilhac, Alexandre Willaume, Chloe Antier, Julien Lazarovici, Emilie Leveque, Pierre Decazes, Stéphanie Becker, David Tonnelet, Alina Berriolo-Riedinger, Philippe Gaulard, Herve Tilly, Thierry Jo Molina, Alexandra Traverse-Glehen, Fabrice Jardin
High PDL1/PDL2 gene expression correlates with worse outcome in primary mediastinal large B-cell lymphoma. Blood advances (2023)
Jean Lemoine, Emmanuel Bachy, Guillaume Cartron, David Beauvais, Thomas Gastinne, Roberta Di Blasi, Marie-Thérèse Rubio, Stéphanie Guidez, Mohamad Mohty, Olivier Casasnovas, Magalie Joris, Cristina Castilla-Llorente, Corinne Haioun, Olivier Hermine, Michael Loschi, Sylvain Carras, Pierre Bories, Tom Fradon, Charles Herbaux, Pierre Sesques, Steven Le Gouill, Judith Trotman, Catherine Thieblemont, Roch Houot
Non-Relapse Mortality after CAR T-Cell therapy for Large B-Cell Lymphoma: A LYSA Study from the DESCAR-T Registry. Blood advances (2023)
Marion Subklewe, Yucai Wang, Omar Albanyan, Javier Munoz, Pierre Sesques, Gloria Iacoboni, Lucia Lopez-Corral, Isabelle Ries, Veit L Bücklein, Razan Mohty, Martin Dreyling, Aliyah Baluch, Bijal D Shah, Frederick L Locke, Georg Hess, Pere Barba, Emmanuel Bachy, Yi Lin, Marion Subklewe, Michael D Jain
The CAR-HEMATOTOX score identifies patients at high risk for hematological toxicity, infectious complications, and poor treatment outcomes following brexucabtagene autoleucel for relapsed or refractory MCL. American journal of hematology (2023)
Ryan N Rys, Claudia M Wever, Dominique Geoffrion, Christophe Goncalves, Artin Ghassemian, Eugene Brailovski, Jeremy Adam Ryan, Liliana Stoica, Josée Hébert, Tina Petrogiannis-Haliotis, Svetlana Dmitrienko, Saul Frenkiel, Annette M Staiger, German Ott, Christian Steidl, David W Scott, Pierre Sesques, Sonia Del Rincon, Koren K Mann, Anthony G Letai, Nathalie A Johnson
Apoptotic Blocks in Primary Non-Hodgkin B Cell Lymphomas Identified by BH3 Profiling. Cancers 13 (5) (2021)
Marie-Charlotte Laude, Laure Lebras, Pierre Sesques, Herve Ghesquieres, Simon Favre, Krimo Bouabdallah, Carolyne Croizier, Romain Guieze, Laurianne Drieu La Rochelle, Emmanuel Gyan, Roza Chin, Thérèse Aurran-Schleinitz, Amira Marouf, Bénédicte Deau-Fischer, Paul Coppo, Sandrine Malot, Xavier Roussel, Adrien Chauchet, Marianne Schwarz, Charles Bescond, Thierry Lamy de la Chapelle, Lucile Bussot, Sylvain Carras, Bénédicte Burlet, Cédric Rossi, Adrien Daniel, Franck Morschhauser, Fabien Subtil, Anne-Sophie Michallet
First-line treatment of double-hit and triple-hit lymphomas: Survival and tolerance data from a retrospective multicenter French study. American journal of hematology 96 (3) (2020)
Pierre Sesques, Jessie Bourcier, Camille Golfier, Laure Lebras, Emmanuelle Nicolas-Virelizier, Maya Hacini, Marie Claire Perrin, Laurent Voillat, Emmanuel Bachy, Alexandra Traverse-Glehen, Anne Moreau, Laurent Martin, Selim Ramla, Olivier Casasnovas, Steven Le Gouill, Gilles Salles, Hervé Ghesquières
Clinical characteristics and outcomes of relapsed follicular lymphoma after autologous stem cell transplantation in the rituximab era. Hematological oncology 38 (2) (2020)
Pierre Sesques, Emmanuelle Ferrant, Violaine Safar, Florent Wallet, Jérémie Tordo, Anthony Dhomps, Lionel Karlin, Gabriel Brisou, Marlène Vercasson, Carole Hospital-Gustem, Vérane Schwiertz, Florence Ranchon, Catherine Rioufol, Marion Choquet, Pierre Sujobert, Dana Ghergus, Fadhela Bouafia, Camille Golfier, Helène Lequeu, Anne Lazareth, Silvana Novelli, Perrine Devic, Alexandra Traverse Glehen, Sébastien Viel, Fabienne Venet, Valérie Mialou, Olivier Hequet, Adrien Chauchet, Yazid Arkam, Emmanuelle Nicolas-Virelizier, Frederic Peyrade, Doriane Cavalieri, Florence Ader, Hervé Ghesquières, Gilles Salles, Emmanuel Bachy
Commercial anti-CD19 CAR T cell therapy for patients with relapsed/refractory aggressive B cell lymphoma in a European center. American journal of hematology 95 (11) (2020)

Pierre Sesques.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Pierre Sesques